GENEART Supports the UK HIV Vaccine Consortium (UK HVC) in Developing a DNA Vaccine Candidate against HIV
19-Jun-2009 -
GENEART AG announced being awarded a contract for the design and production of two DNA vaccine candidates against HIV by the UK HVC. The genes, optimized and customized by GENEART, are to be used as basis for clinical studies.
Two gene constructs, developed by GENEART in cooperation with the ...
cell cultures
clinical trials
Geneart
+2